19
Views
12
CrossRef citations to date
0
Altmetric
Original Article

Human Cell Mediated Immunity to Porins from Salmonella typhi

, , , , , & show all
Pages 73-80 | Published online: 07 Feb 2010

References

  • Edelman R, Levine M M. Summary of a workshop on typhoid fever. Rev Infect Dis 1986; 8: 329–349
  • Jo I. International conference on the application of vaccines against viral. Rickettsial and bacterial disease of man. PAHO/WHO Scientific Publication, Washington, DC 1970; 226: 339–341
  • Wandan M H, Serie C, Cerisier Y, Sallam S, Germanier G. Controlled field trial of live Salmonella typhi strain Ty 21a oral vaccine against typhoid: three years results. J Infect Dis 1982; 145: 292–295
  • Germanier R. The live oral typhoid vaccine Ty 21a: Recent field trial results. Bacterial vaccines in local immunity. Sclavo International Conference. SienaItaly 1986
  • Robbins J D, Robbins J B. Re-examination of the immunopathogenic role of the capsular polysaccharide (Vi antigen) of Salmonella typhi. J Infect Dis 1984; 47: 436–449
  • Osborn M J, Wu H C. Proteins of the outer membrane of Gram-negative bacteria. Annu Rev Microbiol 1980; 34: 369–422
  • Wang L I, Frash C E. Development of a Neisseria meningitidis Group B serotype 2b protein vaccine and evaluation in a mouse model. Infect Immun 1984; 46: 408–414
  • Buchanan T M, Pearce W A, Schoolnick G K, Arko R J. Protection against infections with Neisseria gonorrhoeae by immunisation with outer membrane protein complex and purified pili. J Infect Dis 1977; 136: 132–137, Suppl.
  • Adamus G, Mulczka M, Witkowska D, Romanowska E. Protection against keratoconjunctivitis shigellosa induced by immunisation with outer membrane proteins of Shigella sp. Infect Immun 1980; 30: 321–324
  • Caldwell H D, Perry L P. Neutralization of Chlamydia trachomatis infectivity with antibodies to the major outer membrane protein. Infect Immun 1982; 38: 745–754
  • Gilleland H E, Parker M G, Matthews J W, Berg R D. Use of purified outer membrane protein F (porin) preparation of Pseudomonas aeruginosa as a protective vaccine in mice. Infect Immun 1984; 44: 49–54
  • Lenoir A A, Granoff P D, Granoff D M. Immunogenicity of Haemophilus influenzae type b polysaccharide-Neisseria meningitidis outer membrane protein conjugate vaccine in 2- to 6-month-old infants. Pediatrics 1987; 80: 283–287
  • Guling P A, McCracken G H, Jr, Frich C F, Johnston K H, Hansen E J. Antibody response of infants to cell surface-exposed outer membrane proteins of Haemophilus influenzae type b after systemic Haemophilus disease. Infect Immun 1982; 37: 82–88
  • Kussi N, Nurminen M, Saxon H, Mäkelä P H. Immunization with major outer membrane protein (porin) preparations in experimentál murine salmonellosis: Effect of lipopolysaccharide. Infect Immun 1981; 34: 328–332
  • Svenson S B, Nurminen M, Lindberg A A. Artificial Salmonella vaccines: O-antigenic oligosaccharide-protein conjugates induce protection against infection with Salmonella typhimurium. Infect Immun 1979; 25: 863–872
  • Kussi N, Nurminen M, Saxon H, Valtonen M, Mäkelä P H. Immunization with outer major membrane proteins in experimental salmonellosis of mice. Infect Immun 1979; 25: 857–862
  • Ortiz V, Isibasi A, García-Ortigoza E, Kumate J. Immunoblot detection of class-specific humoral immune response to outer membrane proteins isolated from Salmonella typhi in humans with typhoid fever. J Clin Microbiol 1989; 27: 1640–1645
  • Eisen H N, Siskind G W. Variations in affinities of antibodies during the immune response. Biochemistry 1969; 3: 996–1008
  • Scott P, Kaufmann H E. The role of T-cell subsets and cytokines in the regulation of infection. Immunology Today 1991; 12: 346–348
  • Schnaitman C A. Effect of ethylenediamine tetraacetic acid, Triton X-100 and lysozyme on the morphology and chemical composition of isolated cell walls of Escherichia coli. J Bacteriol 1971; 108: 553–556
  • Nikaido H. Proteins forming large channels from bacterial and mitochondrial outer membranes: porins and phage lambda receptor protein. Methods Enzymol 1983; 97: 85–100
  • Levine M M, Ferrecio C. Typhoid vaccines. Lancet 1988; 173
  • Udhayakumar V, Muthukkaruppan V R. Characteristics of live vaccines in relation to delayed type hypersensitivity and protective immunity in murine experimental salmonellosis. Immunol Lett 1983; 6: 299–302
  • Ferrecio C, Levine M M, Rodriguez H, Contreras R. Comparative efficacy of two, three or four doses of Ty 21a live oral typhoid vaccine in enteric-coated capsule; a field trial in an endemic area. J Infect Dis 1989; 159: 766–769
  • Simanjuntak C H, Paleologo F P, Punjabi N H, Darmowigoto Ruwido, Totosudirjo S H, Haryanto Pujarwoto, Suprijanto Eko, Witham N D, Hoffman S L. Oral immunization against typhoid fever in Indonesia with Ty 21a vaccine. Lancet 1991; 338: 1055–1059
  • Forrest B D. Identification of an intestinal immune response using peripheral blood lymphocytes. Lancet 1988; I: 81–83
  • Fujio Y. DNA and amino acid sequences of outer membrane proteins and lipoproteins, M Inouye. John Wiley and Sons. 1987; 419–432
  • Mizuno T, Chou M Y, Inouye M. A comparative study on the genes for three porins of the Escherichia coli outer membrane DNA sequence of osmoregulation omp C gene. J Biol Chem 1983; 258: 6932–6940

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.